These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35341635)

  • 1. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].
    Hu C; Liu S; Han M; Wang Y; Xu C
    Biomed Pharmacother; 2022 May; 149():112795. PubMed ID: 35282972
    [No Abstract]   [Full Text] [Related]  

  • 3. RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma.
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2019 Jan; 109():798-805. PubMed ID: 30551533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.
    Wen D; Li S; Jiang W; Zhao S; Liu J; Zhu J
    Biomed Pharmacother; 2023 Oct; 166():114877. PubMed ID: 37353385
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2022 Jan; 145():112511. PubMed ID: 34895810
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "MicroRNA-19a promotes cell viability and migration of chondrocytes via up-regulating SOX9 through NF-κB pathway" [Biomed. Pharmacother. 98 (2018) 746-753].
    Yu C; Wang Y
    Biomed Pharmacother; 2022 May; 149():112790. PubMed ID: 35282974
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells" [Biomed. Pharmacother. 109 (2019) 2456-2463].
    Fang L; Xu W; Kong D
    Biomed Pharmacother; 2022 Jun; 150():112851. PubMed ID: 35341632
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "MicroRNA-497 promotes proliferation and inhibits apoptosis of cardiomyocytes through the downregulation of Mfn2 in a mouse model of myocardial ischemia-reperfusion injury" [Biomed. Pharmacother. 105 (2018) 103-114].
    Qin L; Yang W; Wang YX; Wang ZJ; Li CC; Li M; Liu JY
    Biomed Pharmacother; 2023 Sep; 165():114741. PubMed ID: 37353380
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
    Xia H; Jing H; Li Y; Lv X
    Biomed Pharmacother; 2023 Dec; 169():115376. PubMed ID: 38016887
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2" [Biomed. Pharmacother. 104 (2018) 411-419].
    Ling L; Zhang SH; Zhi LD; Li H; Wen QK; Li G; Zhang WJ
    Biomed Pharmacother; 2023 Sep; 165():114767. PubMed ID: 37183051
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
    Sun B; Zhang J; Liu M; Guan L
    Biomed Pharmacother; 2022 Feb; 146():112626. PubMed ID: 35031232
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p" [Biomed. Pharmacother. 117 (2019) 109153].
    Xu C; Hu C; Wang Y; Liu S
    Biomed Pharmacother; 2022 Jun; 150():112857. PubMed ID: 35341639
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106" [Biomed. Pharmacother. 107 (2018) 1583-1590].
    Jiang L; Song H; Guo H; Wang C; Lu Z
    Biomed Pharmacother; 2020 Oct; 130():110634. PubMed ID: 32843236
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724].
    Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
    Biomed Pharmacother; 2024 Feb; 171():116187. PubMed ID: 38296728
    [No Abstract]   [Full Text] [Related]  

  • 17. Long non-coding RNA
    Li L; Chen W; Wang Y; Tang L; Han M
    Oncol Lett; 2018 Jun; 15(6):8424-8432. PubMed ID: 29805578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 19. LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway.
    Liu F; Yang XC; Chen ML; Zhuang ZW; Jiang Y; Wang J; Zhou YJ
    Am J Transl Res; 2020; 12(4):1338-1347. PubMed ID: 32355545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2023 Nov; 167():115375. PubMed ID: 37802728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.